Sekisui Diagnostics

Sekisui Diagnostics logo

Sekisui Diagnostics, a global provider of innovative medical diagnostics to physicians and laboratories, has been committed to improving the lives of patients for over 30 years. We continue to invest in new diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. We are a leading provider of rapid tests in the U.S., and high throughput coagulation systems in Japan. We develop, manufacture, and supply over 1.7 billion tests each year to the global healthcare market through direct sales, our commercial distribution networks and our partners.

Contact Sekisui via their website

News archive

04/02/2020   Sekisui Chemical Co recognized as one of the Most Sustainable Corporations in the World...more

24/11/2019   Sekisui Diagnostics Opens $1.9 Million Bioprocess Innovation Centre...more

24/10/2019   Sekisui Invests $1.9m in New Bioprocess Innovation Centre in the UK...more

07/09/2019   Sekisui Diagnostics Announces FDA Clearance AcucyTM Influenza Test...more

11/09/2019   Sekisui Diagnostics Announces Launch of New SilarisĀ® Molecular RSV Test...more

09/07/2019   Sekisui Diagnostics Announces Relocation of Global Headquarters...more

14/05/2019   Sekisui Diagnostics invests $1.9 million in new Maidstone BioProcess Innovation Centre...more

18/04/2019   Sekisui Diagnostics Announces the Launch of the FastPack® IP SHBG Test...more
28/02/2019   Sekisui Diagnostics PEI Expands with more Jobs...more

13/12/2018   Sekisui Diagnostics PEI in Canada's Top 100 Employers...more
26/09/2018   Sekisui Diagnostics joins the BioPartner programme...more
30/07/2018   Sekisui Diagnostics Receives SEKURE® HbA1c FDA Clearance...more

The BioPartner Programme

BPP members enjoy our full range of discounts, enhanced promotion on BioPartner UK Delegations and first refusal on new international opportunities.

Not a member? Join the BioPartnership Programme

BioPartner UK is a member of

Sponsors Alliance

Prompt Payment Code